The Effect of Hydroalcoholic Extract of Senna (Cassia Angustifolia Vahl.) on Lipid Profiles in Hyperlipidemic Rats

Background: Abnormality in metabolism of lipids and hyperlipidemia is a risk factor for atherosclerosis which is the major cause of cardiovascular diseases (CVDs). Several herbal drugs are used for the treatment of dyslipidemia. The present study investigates the effects of hydroalcoholic extracts of Senna extract on serum lipid profile among hyperlipidemic rats. Methods: Forty eight male Wistar rats were randomly divided into 6 groups of 8 animals, including group 1) normal pellet diet (control), group 2) high fat diet (HFD), group, 3) HFD with 100 mg/kg Senna extract treatment, group 4) HFD with 200 mg/kg Senna extract treatment, group 5) 100 mg/kg pure Senna extract, and group 6) 200 mg/kg pure Senna extract. All the dietary regimens and Senna extract treatments were continued for 30 days. At the end of the experiment, blood samples collected from heart of rats and the lipid profile levels were measured. Results: The results indicated that short-term treatment by hydroalcoholic of Senna extract produced a significant reduction in the level of cholesterol, triglyceride, and LDL-C (P < 0.05), as well as an increase in HDL-C. The body weight in the HFD group was significantly higher than the other groups (P < 0.05). Conclusion: Prescription of hydroalcoholic extracts of Senna is effective in the treatment of hyperlipidemia, and can inhibit the weight gain induced by HFD in rats. Some of these effects could be attributed to antioxidants activities, biological and pharmaceutical properties and other protective properties of the Senna extract requiring further investigations.

The effects of omega 3 fatty acids on the serum concentrations of pro inflammatory cytokines anddepression status in patients with bipolar disorder: A randomized double-blind controlled clinical trial

Background

The inflammation accelerates the progression of bipolar disorder. Supplementation of anti-inflammatory supplements in adjuvant with medications may alleviate disorder signs. This study aimed to investigate the effects of omega-3 fatty acid supplementation on the serum concentrations of pro-inflammatory cytokines and depression status in patients with bipolar disorder.

Materials and Methods

This randomized clinical trial study was conducted in Zahedan city in 2021. Patients with bipolar disorder (n = 60) were grouped into two groups: omega-3 fatty acid supplement group (n = 30, 15 men and 15 women) and placebo one using a permuted block stratified randomization. The patients in the omega-3 group received 2 g of omega-3 fatty acids daily for 2 months while patients in the placebo group received 2 g soft gels daily in the same form. Depression score and the serum concentrations of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP) were assessed before and after the study.

Results

Depression score and the serum concentrations of TNF-α, IL-6, and hs-CRP were decreased after intervention in the omega-3 fatty acid group also compared with the placebo group (P < 0.001). The results also show a positive correlation between the serum concentrations of TNF-α, IL-6, and hs-CRP with depression scores (P < 0.001).

Conclusion

Prescription of omega-3 fatty acids can decrease inflammatory parameters and help to decrease depression in patients with bipolar disorder. This supplement can be used along with medications for decreasing the inflammatory markers in these patients.